Model
Edge
Lumos Pharma
LUMO
Filing Type
8-K
Filing Date
12/11/2024
Updated
12/12/24, 8:28 AM
Filing
8-K
Earnings Release
Exhibits
8-K
End of Material Contract, Completing Asset Acquisition or Sale, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Material Modifications to Rights of Security Holders, Change in Company Ownership, Changes in Board, Management or Compensation, Amendments to Articles of Incorporation or Bylaws, Other Events
EX-2.2
EX-2.2
EX-3.1
EX-3.1
EX-3.2
EX-3.2